We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Acute Gastroenteritis May Lead to Heart Disease

By LabMedica International staff writers
Posted on 09 Dec 2010
People who become infected with Escherichia coli have a higher risk of subsequently developing hypertension, heart disease, and kidney problems. More...


Individuals who have become infected with E. coli 0157:H7 and/or Campylobacter and suffered from acute gastroenteritis may have an increased risk of chronic diseases associated with high blood pressure and renal impairment.

An assessment was made at Victoria Hospital, (London, Ontario, Canada), of 4,561 people who had been exposed to a tainted municipal water system in May 2000. The water had been infected with Campylobacter and E. coli 0157:H7 bacteria. The long-term health of 1,977 individuals who had developed gastroenteritis was evaluated as 1,067 of them became ill with acute gastroenteritis, and 378 sought help from a physician. Of the 131 stool samples tested for pathogens, 19% were positive for E. coli O157:H7, 19% were positive for Campylobacter, and 1.5% showed coinfection. This prospective cohort study was conducted from 2002 until 2008.

Structural and functional renal impairment were defined as microalbuminuria (albumin:creatinine ratio greater than 2.0 mg/mmol in men and more than 2.8 mg/mmol in women) and estimated glomerular filtration rate less than 60 mL/min/1.73 m2, respectively. Two classifications of renal impairment were analyzed: the presence of either indicator of renal impairment and the presence of both indicators.

The investigators discovered that those who had developed gastroenteritis symptoms had a 1.3 higher risk of developing hypertension (high blood pressure) compared to those who had not become infected. Renal impairment (kidney problem) risk was 3.4 times higher, and the chances of having a cardiovascular event, such as stroke or heart attack were 2.1 times higher. Recent research suggests that the presence of both structural and functional renal impairment is a stronger predictor of mortality, cardiovascular morbidity, and renal decline than either structural or functional renal impairment alone.

The authors concluded that their findings underline the need for following up individual cases of food or water poisoning by E. coli O157:H7 to prevent or reduce silent progressive vascular injury. These long-term consequences emphasize the importance of ensuring safe food and water supply as a cornerstone of public health.

The study was published November 17, 2010, in the British Medical Journal.

Related Links:

Victoria Hospital


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Host Response Immunoassay Test
MeMed BV
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.